How much is MBX Biosciences worth in 2026?

MBX Biosciences has a current valuation of N/A based on their Later Stage VC (Series C) round and secondary market data.

How much funding has MBX Biosciences raised?

MBX Biosciences has raised N/A in total funding across 3 funding rounds.

MBX Biosciences

Drug Discovery

MBX Biosciences valuation and funding history | Last updated: August 2, 2024 | 3 funding rounds

Current Valuation

N/A

As of August 2, 2024

Total Funding Raised

N/A

Across 3 rounds

Last Round

Later Stage VC (Series C)

$63.5M

Last Funding

Aug 2024

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
August 2, 2024	Later Stage VC (Series C)	$63.5M	N/A	-
November 7, 2022	Early Stage VC (Series B)	$115.0M	N/A	-
January 1, 2022	Seed Round	Undisclosed	N/A	-

Valuation Analysis

Current Valuation Metrics

MBX Biosciences is currently valued at N/A as of August 2, 2024.

Track MBX Biosciences Valuation Updates

Get notified when MBX Biosciences raises new funding or valuation changes

Explore More Data

Detailed analysis for MBX Biosciences

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock MBX Biosciences's valuation history, funding rounds, and growth metrics.

No credit card required

What is MBX Biosciences Worth in 2026?

MBX Biosciences is a leading private company in the Drug Discovery sector. Track MBX Biosciences's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How MBX Biosciences Valuation is Determined

Private company valuations like MBX Biosciences's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.